Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
4 - Why can't information from a study be used if the reference appears in the bibliography section of the Product Monograph?
-
All claims must be consistent with the Product Monograph. In the past, we have been advised by Health Canada that the inclusion of a study in a drug submission/bibliography section is not indicative of the approval of all parameters of that study. There must be proof of acceptance of the information evidenced by inclusion in the text of the Product Monograph. We can ask Health Canada for a product monograph interpretation. We have no control over when Health Canada answers and they may ask to see the advertising. The PAAB will not release submission information without the written approval of the submitter.
